The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Paysign (PAYS) is solidifying its market position by leveraging its dominant 50% share in the plasma center segment. The company has announced aggressive expansion plans, aiming to add 115 new centers during the 2025 fiscal year to broaden its footprint. Beyond its core payment services, Paysign is strategically pivoting toward high-margin SaaS revenue through its advanced BECS system. This transition, combined with rapid growth in the Patient Affordability segment, reflects a shift toward more sustainable, recurring revenue streams. While revenue-per-center has seen temporary fluctuations, the overall growth trajectory for the company remains robust. Analysts view Paysign's market leadership and diversification into subscription-based software as key drivers for long-term value.
Sign up free to access this content
Create Free Account